Moving Foward With Myeloma (MFM)
ConditionMultiple Myeloma (MM)
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMedical College of Wisconsin
About this trial
The purpose of this project is to evaluate the impact of a 16-week lifestyle program that promotes changes in eating and exercise patterns. The main questions the study will answer are:
Do improvements in eating and exercise patterns lead to improved physical function, quality of life and blood biomarkers of biologial aging among individuals with multiple myeloma? Participants will complete study activities 3-4 times during the study.
1. In-person assessment to measure physical function, height/weight, body composition, and includes a blood draw 2. Surveys completed online or on paper at home
Eligibility criteria
Qualifiers
Adult (≥ 18 years)
Diagnosed with MM at least one year prior to study enrollment
Has access to a cell phone
no near-term changes in planned myeloma-directed therapy anticipated. (e.g., patient who is 3 months from autologous stem cell transplant just starting on maintenance lenalidomide is eligible since maintenance is planned therapy following transplant)
Disqualifiers
Individuals with <6 months of life anticipated, coexistent amyloidosis, and/or receiving appetite stimulants will not be approached
Fully adherent to the ACS nutrition and physical activity guidelines
Currently pregnant or lactating, or anticipating pregnancy
On another interventional clinical trial that precludes co-enrollment
Trial design
Treatments tested in this trial
- Immediate intervention
- Waitlist
Treatment groups
184 Participants
are divided into 2 treatment groupsSponsors and collaborators
Medical College of Wisconsin
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Loyola University Chicago
Collaborator
Source ClinicalTrials.gov